CN Hayes, M Imamura, H Aikata… - Nature reviews …, 2012 - nature.com
The IL28B locus attracted the attention of HCV researchers after a series of genome-wide association studies independently identified a strong association between common IL28B …
Y Suzuki, K Ikeda, F Suzuki, J Toyota, Y Karino… - Journal of …, 2013 - Elsevier
Background & Aims Improved therapeutic options for chronic hepatitis C virus (HCV) infection are needed for patients who are poor candidates for treatment with current …
Background & Aims The extent of liver fibrosis predicts long-term outcomes, and hence impacts management and therapy. We developed a non-invasive algorithm to stage fibrosis …
Background Since 2009, several studies have identified single-nucleotide polymorphisms (SNPs) near the gene encoding for interleukin (IL)-28 (IL28B) that are strongly associated …
P Ramachandran, A Fraser, K Agarwal… - Alimentary …, 2012 - Wiley Online Library
Background The nonstructural 3 serine protease inhibitors (PI s), boceprevir and telaprevir, represent the first in a new generation of directly acting antivirals against genotype 1 …
K Ura, N Furusyo, E Ogawa, T Hayashi… - Alimentary …, 2016 - Wiley Online Library
Summary Background The Wisteria floribunda agglutinin‐positive human Mac‐2‐binding protein (WFA+‐M2 BP) is a new liver fibrosis glycobiomarker with unique fibrosis‐related …
Direct-acting antiviral drugs (DAAs) are currently replacing antiviral therapy for Hepatitis C infection. Treatment related side effects are even worse and the emergence of resistant …
Background & Aims Polymorphisms in interferon (IFN) L3 (encodes IFNλ3 or interleukin 28B) are associated with outcomes of treatment for hepatitis C virus (HCV) infection …
Background/Aims Polymorphism at the IL28B gene may modify the course of hepatitis C virus (HCV) chronic infection. Our aim was to study the influence of IL28B rs12979860 gene …